MARLBOROUGH, Mass. – CeQur, a developer of insulin delivery devices, has acquired the assets of Johnson & Johnson’s Calibra Medical, including the worldwide license for the wearable, on-demand insulin delivery system, previously known as OneTouch Via, which enables people with diabetes to deliver rapid-acting insulin at mealtime. “Clinical studies and real-world experience have shown that wearable, on-demand insulin delivery provides are an ideal solution to the pervasive challenge of mealtime insulin delivery,” said Robert Farra, CEO of CeQur, in a statement. “The Calibra device is a perfect complement to our basal and bolus insulin-infusion device. Both wearable devices provide simple, discreet, three-day insulin delivery without the barriers and discomfort created by injections.” CeQur plans to launch Calibra’s insulin delivery device under a new name in mid-2019.
You are here: / / CeQur acquires assets of J&J’s Calibra